Skip to main content

ENzymatic DEcontamination TECHnology

Objective

Human activities are associated with increasing amounts of waste that ultimately find their ways into European waters and have negative consequences on the environment. With the background of an aging population and increasing urbanization, wastewater treatment must specifically target pharmaceutical products (PPs) and endocrine disrupting chemicals (EDCs) so that these highly biologically-active compounds are eliminated from the water resource.

If conventional treatment technologies are very efficient on a large number of compounds, some chemicals, such as pharmaceutical residues and endocrine disruptors, are recalcitrant and are not removed. The chronic exposure to these compounds is a topic of threat as the long term effects are so far unpredictable and undocumented. This issue has recently drawn the interest of many medical professionals, eco-toxicologists and environmental and health agencies.
The global objective of the ENDETECH program is to develop a technology which aims at eliminating persistent pharmaceutical pollutants in wastewaters originating from drug manufacturing sites, households, hospitals and animal farms, thanks to an innovative ENzymatic DEcontamination TECHnology.

The pharmaceutical pollutants targeted in priority during this project will be antibiotics, hormones and endocrine disruptors.

The ENDETECH program is articulated around three main steps: (1) enzyme libraries will be screened to identify novel enzymes able to inactivate the selected pollutants; (2) the discovered enzymes will be immobilized on beads or membranes and subsequently (3) used in bioreactors to decontaminate waste effluents.

The ENDETECH consortium includes all the needed and complementary skills for the project in the fields of enzyme screening, optimization and immobilization, bioreactor development & design and chemical & eco-toxicological analysis. The ENDETECH network is composed of 3 SMEs and 3 RTD organizations.

Call for proposal

FP7-ENV-2011-ECO-INNOVATION-TwoStage
See other projects for this call

Coordinator

DA VOLTERRA SAS
Address
Rue De Charonne 172 Le Dorian Batiment B
75011 Paris
France
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 450 888,50
Administrative Contact
Florence Sejourne (Ms.)

Participants (5)

C-LECTA GMBH
Germany
EU contribution
€ 291 204,60
Address
Perlickstrasse 5
04103 Leipzig
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Stefan Schönert (Dr.)
CHIRALVISION BV
Netherlands
EU contribution
€ 289 406,50
Address
Hoog-harnasch 44
2635 DL Den Hoorn
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Rob Schoevaart (Dr.)
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
France
EU contribution
€ 511 240,40
Address
Rue Michel Ange 3
75794 Paris
Activity type
Other
Administrative Contact
Jocelyn Mere (Dr.)
FUNDACIO INSTITUT CATALA DE RECERCA DE L'AIGUA
Spain
EU contribution
€ 218 838
Address
Calle Emili Grahit Edifici H20 101
17003 Girona
Activity type
Research Organisations
Administrative Contact
Jaume Alemany (Dr.)
JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN
Germany
EU contribution
€ 233 070
Address
Theodor W Adorno Platz 1
60323 Frankfurt Am Main
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Jörg Oehlmann (Prof.)